跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,495 条关于
“DPP-IV inhibitors”
全部
26,495
临床试验
17,237
药物
3,962
机构
19
资讯
5,277
7个月前
GLP-1 Receptor Agonists Reduce Amputation Risk and Cardiovascular Events in High-Risk Diabetes Patients
2年前
FDA Approves Zituvimet XR for Type 2 Diabetes
3个月前
GLP-1 Receptor Agonists Linked to Fewer Diabetic Foot Ulcers but Higher Charcot Risk Than DPP-4 Inhibitors
去年
Fosun Pharma Secures $645 Million Global Licensing Deal for Novel DPP-1 Inhibitor XH-S004
上个月
Personalised Medicine and PARP Inhibitors Transform Stage IV Breast Cancer Outcomes: A Decade of Progress in Northern Ireland
去年
Expedition Therapeutics Secures $645M Deal for Chinese DPP-1 Inhibitor in Growing Cross-Border Biotech Trend
去年
SGLT2 Inhibitors Linked to Increased Red Blood Cell Counts But No Thrombotic Risk in Type 2 Diabetes Patients
5年前
SGLT2 Inhibitors Show Promising Results for Elderly with Type 2 Diabetes
去年
GLP-1 Receptor Agonists vs SGLT2 Inhibitors: Comparative Cardiovascular Benefits in Diabetes Management
去年
SGLT-2 Inhibitors Linked to Reduced Dementia and Parkinson's Risk in Type 2 Diabetes Patients
第 1 页,共 528 页
上一页
下一页